| 22 Countries Pledge To 3X Nuclear Power- Uranium Prices Soar 74% (ad) |
|
| Why is this man holding a penny in front of a fusion energy plant? (ad) |
One of America's top commodities experts just stopped by Alabama's biggest fusion energy plant today to share some very important news with you…
One that has to do with the state of the global energy markets… And how our nation's national security might be on the line if we don't act now…
You see, this critical resource is running very low.
And what little is left is being stockpiled by government agencies around the world at the fastest pace in decades.
This could lead to a repeat of this energy resource's BOOM period like we saw in the 2000s…
When top stocks skyrocketed as much as 3,379%, 5,973% even 9,149% in a few short years.
Or it could be much, much bigger.
Don't be left out if that happens.
Go here to get the details. |
|
 Apple Inc. (AAPL)    Amazon.com, Inc. (AMZN)   Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
 Meta Platforms, Inc. (META)  - COO Javier Olivan sold 490 shares of the stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $445.93, for a total value of $218,505.70. Following the sale, the chief operating officer now owns 6,109 shares in the company, valued at approximately $2,724,186.37. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
- (5/8) Turkey's competition board to fine Meta $37.2 million in data-sharing probe (msn.com)
- (5/8) Turkey fines Meta $37.2 million over data-sharing practices (invezz.com)
- (5/8) Why Meta Platforms Stock Lost 12% in April (fool.com)
- (5/8) Social media firms must tackle 'toxic algorithms' aimed at children, says Ofcom (proactiveinvestors.co.uk)
- (5/8) Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever (fool.com)
- (5/8) Don't Sleep on Meta Platforms Stock. Why Its AI Bet Could Pay Off Big. (investorplace.com)
- (5/8) Here's the Real Winner From Meta Platforms' Latest Announcement (fool.com)
- (5/8) The 3 Most Undervalued Growth Stocks to Buy in May 2024 (investorplace.com)
- (5/8) Next Bull Wave: 7 Stocks Ready to Dominate in the Upcoming Rally (investorplace.com)
- (5/8) Meta Platforms, Inc. (NASDAQ:META) COO Sells $218,505.70 in Stock (insidertrades.com)
 Microsoft Co. (MSFT)  - ADTRAN (NASDAQ:ADTN) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $7.50 price target on the stock. This represents a 33.5% upside from the current price of $5.62.
- Alignment Healthcare (NASDAQ:ALHC) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $8.00 price target on the stock, up previously from $6.00. This represents a 16.1% upside from the current price of $6.89.
- Aterian (NASDAQ:ATER) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating.The current price is $2.75.
- Confluent (NASDAQ:CFLT) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $28.00. This represents a 16.6% upside from the current price of $30.03.
- Confluent (NASDAQ:CFLT) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock. This represents a 16.6% upside from the current price of $30.03.
- Crexendo (NASDAQ:CXDO) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $5.75 price target on the stock, down previously from $6.75. This represents a 44.1% upside from the current price of $3.99.
- Datadog (NASDAQ:DDOG) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $140.00 price target on the stock, up previously from $130.00. This represents a 19.9% upside from the current price of $116.80.
- Energizer (NYSE:ENR) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $33.00 price target on the stock. This represents a 12.6% upside from the current price of $29.32.
- Envestnet (NYSE:ENV) was upgraded by analysts at Jefferies Financial Group Inc. from an "underperform" rating to a "hold" rating. They now have a $59.00 price target on the stock, up previously from $47.00. This represents a 5.9% downside from the current price of $62.73.
- ExlService (NASDAQ:EXLS) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $40.00 price target on the stock, up previously from $34.00. This represents a 31.1% upside from the current price of $30.52.
- HireRight (NYSE:HRT) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $14.36.
- Hexcel (NYSE:HXL) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $95.00 price target on the stock, up previously from $81.00. This represents a 30.8% upside from the current price of $72.65.
- International Flavors & Fragrances (NYSE:IFF) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $75.00. This represents a 3.0% upside from the current price of $97.10.
- Myriad Genetics (NASDAQ:MYGN) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $25.00. This represents a 53.6% upside from the current price of $22.78.
- Nutanix (NASDAQ:NTNX) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $72.00 price target on the stock. This represents a 8.2% upside from the current price of $66.57.
- Old Dominion Freight Line (NASDAQ:ODFL) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $205.00 price target on the stock. This represents a 11.9% upside from the current price of $183.18.
- Orthofix Medical (NASDAQ:OFIX) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $20.00 price target on the stock, up previously from $15.00. This represents a 30.5% upside from the current price of $15.32.
- Redfin (NASDAQ:RDFN) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $9.00 price target on the stock, up previously from $8.00. This represents a 42.6% upside from the current price of $6.31.
- Boston Beer (NYSE:SAM) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating. They now have a $273.00 price target on the stock. This represents a 2.2% downside from the current price of $279.05.
- View today's most recent analysts' upgrades at MarketBeat.com
| Controversial CEO: My money secret could work for you too (ad) |
There's no shortage of controversial CEOs in America today...
From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon...
But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...
Don't miss Porter's brand-new presentation on this subject |
|
- A-Mark Precious Metals (NASDAQ:AMRK) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating.The current price is $38.00.
- Beyond (NYSE:BYON) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $15.90.
- Definitive Healthcare (NASDAQ:DH) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $9.00 price target on the stock, down previously from $11.50. This represents a 81.1% upside from the current price of $4.97.
- DoubleVerify (NYSE:DV) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $18.54.
- Golub Capital BDC (NASDAQ:GBDC) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $16.69.
- Inspire Medical Systems (NYSE:INSP) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $225.00 price target on the stock, down previously from $265.00. This represents a 38.3% upside from the current price of $162.70.
- Jacobs Solutions (NYSE:J) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $139.16.
- WK Kellogg (NYSE:KLG) was downgraded by analysts at BNP Paribas from a "neutral" rating to an "underperform" rating. They now have a $20.00 price target on the stock. This represents a 11.8% downside from the current price of $22.67.
- Mercantile Bank (NASDAQ:MBWM) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.The current price is $39.40.
- Nasdaq (NASDAQ:NDAQ) was downgraded by analysts at Rosenblatt Securities from a "buy" rating to a "neutral" rating. They now have a $64.00 price target on the stock, down previously from $76.00. This represents a 7.0% upside from the current price of $59.82.
- Nuvei (NASDAQ:NVEI) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $34.00 price target on the stock, up previously from $32.00. This represents a 5.4% upside from the current price of $32.26.
- Premier (NASDAQ:PINC) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $21.00 price target on the stock, down previously from $27.00. This represents a 7.3% upside from the current price of $19.57.
- Runway Growth Finance (NASDAQ:RWAY) was downgraded by analysts at Compass Point from a "buy" rating to a "neutral" rating. They now have a $12.75 price target on the stock. This represents a 4.2% upside from the current price of $12.24.
- Rhythm Pharmaceuticals (NASDAQ:RYTM) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $49.00. This represents a 10.5% upside from the current price of $38.00.
- Saratoga Investment (NYSE:SAR) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating. They now have a $23.00 price target on the stock, down previously from $24.00. This represents a 0.1% downside from the current price of $23.03.
- Shoals Technologies Group (NASDAQ:SHLS) was downgraded by analysts at Roth Mkm from a "buy" rating to a "neutral" rating. They now have a $8.00 price target on the stock, down previously from $15.00. This represents a 7.4% upside from the current price of $7.45.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $4.18.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $8.00 price target on the stock, down previously from $15.00. This represents a 91.4% upside from the current price of $4.18.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $6.00 price target on the stock, down previously from $15.00. This represents a 43.5% upside from the current price of $4.18.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $5.50 price target on the stock, down previously from $15.00. This represents a 31.6% upside from the current price of $4.18.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $7.00 price target on the stock, down previously from $17.00. This represents a 67.5% upside from the current price of $4.18.
- Vishay Precision Group (NYSE:VPG) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $36.00 price target on the stock, down previously from $37.00. This represents a 17.3% upside from the current price of $30.68.
- Victoria's Secret & Co. (NYSE:VSCO) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $14.00 price target on the stock, down previously from $15.00. This represents a 21.2% downside from the current price of $17.76.
- WideOpenWest (NYSE:WOW) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $4.70.
- ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $12.00 price target on the stock, down previously from $19.50. This represents a 1.1% upside from the current price of $11.87.
- ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $24.00. This represents a 26.4% upside from the current price of $11.87.
- ZoomInfo Technologies (NASDAQ:ZI) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $14.00 price target on the stock, down previously from $23.00. This represents a 17.9% upside from the current price of $11.87.
- View today's most recent analysts' downgrades at MarketBeat.com
| How a $0.25 cent option contract makes my top traders feel (ad) |
|
- Chart Industries (NYSE:GTLS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $193.00 price target on the stock. This represents a 23.2% upside from the current price of $156.70.
- Lululemon Athletica (NASDAQ:LULU) is now covered by analysts at BTIG Research. They set a "buy" rating and a $425.00 price target on the stock. This represents a 22.0% upside from the current price of $348.31.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock. This represents a 150.6% upside from the current price of $3.99.
- Sutro Biopharma (NASDAQ:STRO) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 172.1% upside from the current price of $4.41.
- Advanced Drainage Systems (NYSE:WMS) is now covered by analysts at Northcoast Research. They set a "buy" rating and a $190.00 price target on the stock. This represents a 13.1% upside from the current price of $167.94.
- View today's most recent analysts' new coverage at MarketBeat.com
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
| Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: We just added a $200 account credit to your MarketBeat subscription |
|
No comments:
Post a Comment